Neuropsychiatric Adverse Events From Topical Ophthalmic Timolol

Clinical Medicine and Research - United States
doi 10.3121/cmr.2019.1486
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Marshfield Clinic Research Foundation

Related search

Self-Reported Adverse Reactions Associated With Topical Ophthalmic Medication Use: A Cross-Sectional Survey

Drugs and Therapy Studies
2014English

Predictors of Neuropsychiatric Adverse Events With Smoking Cessation Medications in the Randomized Controlled EAGLES Trial

Journal of General Internal Medicine
Internal Medicine
2019English

Topical Timolol for Periocular Hemangioma: Report of Further Study

Archives of Ophthalmology
2011English

Formulation and Evaluation of Some Selected Timolol Maleate Ophthalmic Preparations

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2012English

Peyronie's Disease Following Long-Term Use of Topical Timolol

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2005English

Neuropsychiatric Immune-Related Adverse Events Induced by Pembrolizumab in a Patient With Lung Adenocarcinoma and Systemic Lupus Erythematosus

Internal Medicine
Internal MedicineMedicine
2020English

Deaths From Preventable Adverse Events Originating in Hospitals

BMJ Quality and Safety
MedicineHealth Policy
2017English

Adverse Drug Events in Patients With Dementia and Neuropsychiatric/Behavioral, and Psychological Symptoms, a One-Year Prospective Study

International Journal of Environmental Research and Public Health
MutagenesisPublic HealthEnvironmentalHealthToxicologyOccupational HealthPollution
2019English

936 Systemic Absorption and Safety of Topical Timolol for Chronic Wounds

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy